XDWE:LSE:LSE-Xtrackers (IE) Public Limited Company - Xtrackers S&P 500 Equal Weight UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 7164

Change

-21.00 (-0.29)%

Market Cap

N/A

Volume

0.07M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+3.23 (+1.56%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.12 (-0.86%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.13 (-0.64%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+0.20 (+0.14%)

USD 618.20B
0R1G:LSE Home Depot Inc.

-3.20 (-0.86%)

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

-0.22 (-0.68%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

-0.86 (-1.20%)

USD 266.08B
0QZO:LSE 0QZO

-0.72 (-0.63%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-0.20 (-0.13%)

USD 202.26B
0R24:LSE Intel Corp.

-0.08 (-0.41%)

USD 196.14B

ETFs Containing XDWE:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.14% 17% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.14% 17% F 25% F
Trailing 12 Months  
Capital Gain 2.65% 39% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.65% 34% F 45% F
Trailing 5 Years  
Capital Gain 60.27% 64% D 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 60.27% 61% D- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 12.08% 69% C- 73% C
Dividend Return 12.08% 68% D+ 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.70% 58% F 75% C
Risk Adjusted Return 103.27% 90% A- 94% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike